FOLH1 and prostate carcinoma: In our analysis three times more PSMA SPECT/CT could be analyzed; therefore, relevant data could be evaluated on the integration of PSMA SPECT/CT in the definition of SBRT target volume of low-volume progressing prostate cancer.